DNMT1 as a marker of increased expression of DNA methyltransferases in
lung large-cell neuroendocrine carcinoma patients
Abstract
This is the first study evaluating expression profile of DNMT1,
DNMT3A and DNMT3B genes in lung large cell neuroendocrine
carcinoma patients. Large cell neuroendocrine carcinoma is a subtype of
non-small-cell lung carcinoma with unknown methylation characteristics,
including enzyme activities of DNA methyltransferases. We performed
quantitative expression analyzes of DNMT1, DNMT3A and
DNMT3B genes on formalin-fixed, paraffin-embedded tissue samples
of lung large cell neuroendocrine carcinoma patients, and overexpression
of DNMT1 and an increased normalized expression of both DNMT3A
and DNMT3B genes relative to matched normal lung tissue were
found. In conclusion, we assume that further experiments should be
focused on the detection of individual DNMT3B isoforms in patients with
this type of non-small cell lung carcinoma.